West Des Moines
About Caretta TherapeuticsCaretta Therapeutics was formed by Spotlight Innovation in August 2016 to develop and commercialize products, derived from cobra and rattlesnake venom, that have potential analgesic properties. The products are intended to be available as over-the-counter formulations.
5 articles with Caretta Therapeutics
Spotlight Innovation Subsidiary Caretta Therapeutics Begins The Manufacturing Process For Venodol, A New Over-The-Counter Product To Treat Chronic Pain
Spotlight Innovation Release: Company Subsidiary Caretta Therapeutics Announces Venodol, A New Over-The-Counter Product To Treat Chronic Pain
Spotlight Innovation's Newly Established Subsidiary Caretta Therapeutics Enters Into Exclusive Licensing Agreement To Develop And Commercialize Analgesic Products